Pharmacokinetics and innovative therapeutics
Dr Ben Allal
Pharmacokinetics and theranostic radiolabelled molecules.
Dr Lawrence Dierickx
Quantifying the sources of inter-individual variability in hormone therapy exposure
Dr Fabienne Thomas
Pharmacokinetic modelling of radiolabelled antibodies to understand resistance mechanisms in immunotherapy.
Dr Mélanie White-Koning
Oral therapies: PK/PD relationships and benefit of metabolites in detecting compliance.
Dr Félicien Le Louedec, Dr Florent Puisset
MATADOR and EXPECT projects: identification of new predictive factors for male breast cancer (MATADOR) and young colon cancer (EXPECT).
Dr Christine Toulas